penggunaan antimikroba
TRANSCRIPT
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 1/19
nt m cro a s
sage
an
Dr.
Muhammad
A.
HalwaniSupervisor of Infection Control and
Central Sterilisation in the Makkah Area
Consultant in Infection Control for the Central Board of Accreditation for
Health
Care
Institutions
(CBAHI)
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 2/19
Overview
Antimicrobials including antibiotics are very good agents that are
resistance microorganisms that are difficult to treat and highly
transmissible
The infection control doctor should contribute, advice, and help
treating physicians become more focused before, during, and after su scription re ease
of the wide range of antibiotics and this can be given by medical microbiologist in the hospital
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 3/19
Antimicrobial Resistance
The term resistance can be described to a particular antibiotic if
drug
The term ‘sensitive’ can be described to a particular antibiotic if its
growth was inhibited or by the used concentration of the tested
It must be noted that the microbiology lab results are not 100%
precise an many actors can inter ere wit w at is seen in vitro
them more aware of the possibility of the treatment failure that might happen
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 4/19
Types of Resistance
Natural resistance
Bacteria may have natural resistance to different
antibiotics which
is
usually
the
result
of
the
inability
of
the
drug to penetrate the cells
Acquired
resistance:
The ermeabilit chan e of the cell membrane
Alteration in the target site
Expelling of the drug from the cell
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 5/19
Causes of Resistance Development
The heavy use of antimicrobial agents
Unnecessary prescribing of antimicrobial agents
Inappropriate use such as giving an incorrect agent, ,
prescription
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 6/19
Transmission of Resistance
Cross‐transmission of hospital infections between
es stant
stra ns
sprea
n
t e
same
reg on
w t
pat ent
transfer
Admission of
outside
the
border
patients
who
are
colonised or infected with different strains
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 7/19
Strategies for Preventing Antimicrobial Resistance
Educate in taking an appropriate specimens
Improvements in
prescribing
practice
Simple education to junior doctors and some other
p ys c ans
a e sure t at w e spectrum ant ot cs are use on y
when required with the right dose and duration
Surveillance for resistance strains
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 8/19
Strategies for Preventing Antimicrobial Resistance
cont.,
Isolation of infected & colonised patients
Drug utilization
review
Control and improving in the laboratory testing
Limit the contact between physicians and
p armaceut ca representat ves
reparat on an app cat on o ant ot c po cy
procedures
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 9/19
Antibiotic Policy
The
main
idea
of
the
makin
antibiotic
olic
is:The
main
idea
of
the
makin
antibiotic
olic
is:
hospitals
to minimize the development of antibiotic resistant
strains
to reduce the cost of antibiotic prescribing
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 10/19
Antibiotic Policy cont.,
Antibiotic policy demonstrates a commitment to rational an sensi e use o anti iotics
e po cy s ou cons er t e use o t e narrowest spectrum, which has the minimal toxicity and the least
biograms before preparations
Policy should be prepared by a group of specialised
workers in the hospital or in the region
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 11/19
Antibiotic Policy Committee Members
Clinical pharmacist
An infectious
diseases
doctor
Selected senior consultant could be involved for consultations and suggestions
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 12/19
Committee Members Roles
All
the
members
should
contribute
in
putting
the
policy
an n rev ew ng w care, n para e w e
international standards
Auditing of prescribing is required by a clinical
pharmacist with monthly reporting to the committee
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 13/19
The Ideal Policy
List of the antibiotics in the hos ital and no antibiotic
outside the list should be used
Guidelines should be provided for empiric treatment
an
arge e
rea men
o
e
mos
requen
n ec ons
including dosage and duration of treatment
Protocol
for
surgical
prophylaxis
and
when
they
should
be given and when they should be stopped must be
provided
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 14/19
The Ideal Policy cont.,
Protocol for the reserved antibiotics and who and when
Special forms
in
case
a new
antibiotic
need
to
be
added
or an antibiotic need to be replaced, evaluated or
eliminated to be discussed on the committee meeting
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 15/19
The Ideal Policy cont.,
Infection control doctors have an important role to play in
administrating, and monitoring the drugs prescribed, and in
discussing the
treatment
with
the
physicians
when
therapy
seems
unnecessary
Infection
control
doctors
should
always
direct
physicians
to
the
fact that isolation of microorganisms does not necessarily indicate
, ‐
the course and that the susceptibility of the organism isolated or
switchin to a narrower s ectrum is recommended
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 16/19
Role of Infection Control in Prophylaxis
Antibiotics are also important to protect patients in situations that mar e y increase t eir vu nera i ity to in ection
ey s ou e app e e ore surg ca opera ons or w en
subsequent infection could have very serious consequences such as
valve replacement
Surgeons in any grade (specialists, senior specialist, or consultants) should follow the locally approved or internationally
known policy in selecting proper antibiotics
A point that should be considered always is that prophylactic
thera should not be continued for more than 24 hours
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 17/19
So
what
is
re uired
from
us
as
IC?
Application of simple restriction policy
Minimize the use of some wide spectrum antibiotics and other final hope
treatment
Do not allow for prophylaxis misuse
Suc a group o anti iotics s ou e su scri e on y y consu tants an wit
the support
and
agreement
of
the
medical
microbiologist
P armacy s ou mon tor suc app cat on an s ou not spense restr cte
antibiotics to junior doctors
E ucat ona sess on or c rcu at on o t e ea o suc an app cat on s use u an
mandatory
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 18/19
Antibiotic Control
Antibiotics that must be controlled in the hospital:
Vancomycin/teicoplanin
Third & fourth generation cephalosporins (ceftazidime, ceftriaxone &cefepeme)
Carbepenems (meropenem & imipenem)
Tazocin
Ciprofloxacin
7/23/2019 Penggunaan antimikroba
http://slidepdf.com/reader/full/penggunaan-antimikroba 19/19